Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProMIS Neurosciences Inc. - Common Shares (NQ:PMN)

0.3931 +0.0028 (+0.72%)
Streaming Delayed Price Updated: 12:30 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 353,205
Open 0.3948
Bid (Size) 0.3910 (100)
Ask (Size) 0.3952 (500)
Prev. Close 0.3903
Today's Range 0.3801 - 0.4036
52wk Range 0.3600 - 1.590
Shares Outstanding 32,689,190
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ProMIS Neurosciences Announces Third Quarter 2025 Financial Results & Corporate Highlights
From ProMIS Neurosciences Inc.
Via GlobeNewswire
News headline image
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
From ProMIS Neurosciences Inc.
Via GlobeNewswire

Performance

YTD
-59.1%
-59.1%
1 Month
-14.4%
-14.4%
3 Month
-37.6%
-37.6%
6 Month
-25.8%
-25.8%
1 Year
-59.9%
-59.9%

More News

Read More
News headline image
ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group
From ProMIS Neurosciences Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310
From ProMIS Neurosciences Inc.
Via GlobeNewswire
News headline image
ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights
From ProMIS Neurosciences Inc.
Via GlobeNewswire
News headline image
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank? ↗
Via Benzinga
News headline image
ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference
From ProMIS Neurosciences Inc.
Via GlobeNewswire
News headline image
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
ProMIS Neurosciences Announces Private Placement Financing
From ProMIS Neurosciences Inc.
Via GlobeNewswire
News headline image
Why Vicor Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Tuesday? ↗
Via Chartmill
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
News headline image
Gapping stocks in Tuesday's session ↗
Via Chartmill
News headline image
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
News headline image
ProMIS Neurosciences Announces Private Placement Financing
From ProMIS Neurosciences Inc.
Via GlobeNewswire
News headline image
ProMIS Neurosciences Announces $0.8 Million Registered Direct Offering, Priced At-the-Market Under Nasdaq Rules
From ProMIS Neurosciences Inc.
Via GlobeNewswire
News headline image
Which stocks are experiencing notable movement on Monday? ↗
Via Chartmill
News headline image
Monday's session: most active stocks ↗
Via Chartmill
News headline image
These stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
Nasdaq Surges Over 100 Points; Domino's Shares Fall After Q2 Results ↗
Via Benzinga
News headline image
Dow Gains 50 Points; Verizon Earnings Top Views ↗
Via Benzinga
Topics Stocks
News headline image
Get insights into the top gainers and losers of Monday's pre-market session. ↗
Via Chartmill
News headline image
ProMIS Neurosciences Granted Fast Track Designation by U.S. FDA for PMN310 in the Treatment of Alzheimer’s Disease
From ProMIS Neurosciences Inc.
Via GlobeNewswire

Frequently Asked Questions

Is ProMIS Neurosciences Inc. - Common Shares publicly traded?
Yes, ProMIS Neurosciences Inc. - Common Shares is publicly traded.
What exchange does ProMIS Neurosciences Inc. - Common Shares trade on?
ProMIS Neurosciences Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for ProMIS Neurosciences Inc. - Common Shares?
The ticker symbol for ProMIS Neurosciences Inc. - Common Shares is PMN on the Nasdaq Stock Market
What is the current price of ProMIS Neurosciences Inc. - Common Shares?
The current price of ProMIS Neurosciences Inc. - Common Shares is 0.3931
When was ProMIS Neurosciences Inc. - Common Shares last traded?
The last trade of ProMIS Neurosciences Inc. - Common Shares was at 11/14/25 12:30 PM ET
What is the market capitalization of ProMIS Neurosciences Inc. - Common Shares?
The market capitalization of ProMIS Neurosciences Inc. - Common Shares is 12.85M
How many shares of ProMIS Neurosciences Inc. - Common Shares are outstanding?
ProMIS Neurosciences Inc. - Common Shares has 13M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.